Excretion of THC and its metabolites in ewes' milk

After single iv injections of either 0.02 mg/kg or 1 mg/kg of $\text{[}{}^{14}\text{C}\text{]Δ}{}^9\text{-}\text{tetrahydrocannabinol}$, [¹⁴C]THC, to lactating ewes, radioactivity was detected in the milk at all subsequent time intervals tested (4–96 hr). Radioactivity was found in unchanged THC as well as in various unidentified metabolites. Only about 15% of the administered radioactivity was excreted by the ewes in the first 48 hr; most of this was in the urine and feces. Radioactivity appeared in the feces and urine of a lamb suckling milk from a ewe injected with [¹⁴C]THC, indicating transfer of THC and its metabolites via the milk. These results confirm previous literature reports indicating slow elimination of THC, and show that milk is an additional route of excretion.     

Effects of catecholamine releasing agents on synaptosomal dopamine biosynthesis: Multiple pools of dopamine or multiple forms of tyrosine hydroxylase?

The effects of agents, which are known to induce release of catecholamines from synaptosomes, were assessed on the synthesis of dopamine from tyrosine, as reflected in the evolution of ¹⁴CO₂ from L-[1-¹⁴C]-tyrosine, in intact rat striatal synaptosomes. At a time when release had occured, whereas reserpine inhibited the synthesis of dopamine from tyrosine, with an ED₅₀ of $\text{1 × 10}{}^{\mathrm{?8}}\text{M}$, tyramine (ED₅₀ of $\text{1 × 10}{}^{\mathrm{?5}}\text{M}$) and (+)-amphetamine (ED₅₀ of $\text{1·4 × 10}{}^{\mathrm{?6}}\text{M}$) enhanced the rate of synthesis. The presence of nialamide (10^?4M) or pargyline (10^?3M) had no effect on synaptosomal dopamine synthesis in the absence or presence of amphetamine, tyramine, or reserpine. Neither reserpine, tyramine, nor amphetamine effected the activity of tyrosine hydroxylase or DOPA decarboxylase in the absence of synaptosomal structural integrity. Nor did these drugs effect the accumulation of [³H]-tyrosine into synaptosomes. The data are consistent with the existence of at least two pools of synaptosomal dopamine, one of which can interact with tyrosine hydroxylase. Two hours after pretreatment of rats with 5 mg/kg (+)-amphetamine, the level of synaptosomal dopamine biosynthesis was decreased by 39%. The rate of dopamine synthesis in synaptosomes from amphetamine-pretreated rats was assessed in the presence of reserpine and tyramine. The data are not consistent with alterations in pool size being the only mechanism affecting synaptosomal dopamine synthesis. A mechanism is discussed involving an equilibrium of tyrosine hydroxylase between active and inactive conformers in the presence of an inhibitory pool of dopamine.     

Acute tobacco smoke exposure alters the profile of metabolites produced from benzo[a]pyrene by the isolated perfused rabbit lung

The influence of whole tobacco smoke or the gas phase from smoke on the metabolism of $\text{[}{}^{14}\text{C]benzo}\text{[a]}\text{pyrene}$ was e xamined using the isolated perfused rabbit lung model. Fresh whole tobacco smoke mixed with the air ventilating the perfused lung produces an immediate and dose related decrease in the metabolism of $\text{[}{}^{14}\text{C]benzo}\text{[a]}\text{pyrene}$. The metabolites of $\text{[}{}^{14}\text{C]benzo}\text{[a]}\text{pyrene}$, diols, quinones, phenols and polar compounds are generally decreased in quantity. At the lowest level of smoke administered the percentage of BP-7,8-diol produced is increased dramatically. The results indicate that one of the factors contributing to the carcinogenicity of tobacco smoke may be its ability to produce an immediate alteration in the pulmonary metabolism of polycyclic aromatic hydrocarbons.     

Effect of diphenylhydantoin on the uptake and catabolism of l-[3H]norepinephrine in vitro in rat cerebral cortex tissue

The effect of diphenylhydantoin on the accumulation of [³H]norepinephrine in vitro was examined in brain slices prepared from rat cerebral cortex. High concentrations of diphenylhydantoin (10^?3 M) caused a significant reduction in the 5-min accumulation of [³H]norepinephrine. On the other hand, 10^?5–10^?4 M diphenylhydantoin facilitated the 20-min accumulation of [³H]norepinephrine. This facilitative action of diphenylhydantoin was (1) associated with a reduction in oxidative catabolism of [³H]norepinephrine and (2) abolished by the 2-hr pretreatment of rats with 100 mg/kg of nialamide (i.p.). The inhibitory action of diphenylhydantoin on the oxidative catabolism of [³H]norepinephrine was observed in both whole and lyzed crude synaptosomal preparations. When diphenylhydantoin and pargyline were compared, it was found that pargyline $\text{(}\text{id}{}_{50}\text{= 1.5 × 10}{}^{\mathrm{?6}}\text{M}\text{)}$ was 37 times more effective than diphenylhydantoin $\text{(}\text{id}{}_{50}\text{= 5.5 × 10}{}^{\mathrm{?5}}\text{M}\text{)}$ in inhibiting the oxidative deamination of [³H]norepinephrine. These results suggest that diphenylhydantoin alters norepinephrine metabolism in cerebral cortex slices by an inhibitory action on (1) monoamine oxidase activity and (2) the neuronal uptake system.     

Foetal accumulation of [14C] carbaryl in rats and mice autoradiographic study

Pregnant female rats and mice (18th day) received orally 10 mg/kg of $\text{1-}\text{naphthyl}\text{-N-}\text{methyl}\text{-[}{}^{14}\text{C}\text{]-}\text{carbamate}$ (carbaryl), an anti-cholinesteratic drug. Animals were sacrificed 1, 5, 8, 24, 48, 72 and 96 h after administration and whole-body autoradiography was performed.Autoradiograms of the uterine cavity indicate a placental transfer and a foetal fixation of [¹⁴C] carbaryl metabolites. ¹⁴C-activity can be clearly seen in the foetus from the fifth hour; it persists till birth. We found ¹⁴C-activity in mice 60 h after birth.In both species there are some sites of accumulation in the foetal tissues, mainly in the eyes, central nervous system and liver.     

Mechanisms by which quipazine,a putative serotonin receptor agonist,alters brain 5-hydroxyindole metabolism

Quipazine (2-[1-piperazinyl] quinoline maleate) was shown to increase serotonin and decrease 5-hydroxyindoleacetic acid concentrations in whole brain, several brain regions, and the spinal cord of rats 1 hr after its administration (10 mg/kg, i.p.). In animals with transected spinal cords, quipazine induced stronger activation of extensor reflexes than 5-hydroxytryptophan, chlorimipramine, or Lilly 110140. This response could be blocked by methiothepin. In slices of rat cerebral cortex, quipazine inhibited the uptakes of [³H]-serotonin (EC₅₀ = 10^?6 M) and [³H]-norepinephrine ($\text{EC}{}_{50}\text{= 2 × 10}{}^{\mathrm{?6}}\text{m}$); it was equipotent with Lilly 110140 in inhibiting serotonin uptake, but less potent than chlorimipramine ($\text{EC}{}_{50}\text{= 10}{}^{\mathrm{?7}}\text{m}$). Quipazine administration to rats did not inhibit monoamine oxidase activity, and actually elevated brain tryptophan levels. These observations suggest that the effects of quipazine on brain serotonin and 5-hydroxyindoleacetic acid concentrations could have been caused by direct activation of central serotonin receptors (which would secondarily decrease impulse flow along serotonergic neurones), or by the inhibition of serotonin reuptake, or by both mechanisms.     

Adenosine receptor interactions and anxiolytics

$\text{[}{}^3\text{H}\text{]-N}{}^6\text{-}\text{cyclohexyladenosine}$ and [³H]-1,3-diethyl-8-phenylxanthine label the A₁ subtype of adenosine receptor in brain membranes. The affinities of methylxanthines in competing for A₁ adenosine receptors parallel their potencies as locomotor stimulants. The adenosine agonist N⁶-(-phenylisopropyl) adenosine is a potent locomotor depressant. Both diazepam and $\text{N}{}^6\text{-(}\text{l}\text{-}\text{phenylisopropyl}\text{)}\text{adenosine}$ cause locomotor stimulation in a narrow range of subdepressant doses. Combined stimulant doses of the two agents depress motor activity, as do larger doses of either one, given separately.Evidence supporting and against the hypothesis that some of the actions of benzodiazepines are mediated via the adenosine system is reviewed. A number of compounds interact with both systems, probably because of physico-chemical similarities between adenosine and diazepam. It is concluded that of the four classic actions of benzodiazepines, the sedative and muscle relaxant (but not anxiolytic or anticonvulsant) actions could possibly be mediated by adenosine.     

The effect of bencyclane on the oxidative phosphorylation in isolated mitochondria of heart and liver

Our experiments were designed to localize the inhibitory influence of bencyclane² on the process of oxidative phosphorylation in isolated heart and liver mitochondria. The following results were obtained: (1) The state-3-respiration of rat liver and rabbit heart mitochondria was inhibited by bencyclane. This inhibition was dependent on the substrate used as energy donator, being much more pronounced with glutamate $\text{(}\text{ed}{}_{50}\text{= 3.17 × 10}{}^{\mathrm{?8}}\text{or}\text{1.85 × 10}{}^{\mathrm{?7}}\text{moles/mg}$ of protein, respectively) than with succinate $\text{(}\text{ed}{}_{50}\text{= 3.4 × 10}{}^{\mathrm{?7}}\text{or}\text{4.78 × 10}{}^{\mathrm{?7}}\text{moles/mg}$ of protein, respectively). Since the 2,4-dinitrophenol stimulated respiration was equally inhibited, and glutamate transfer through the mitochondrial membrane not influenced, we assume the NADH-coenzyme-Q-reductase to be the site of interaction at the molecular level. (2) Bencyclane stimulates the state-4-respiration of isolated mitochondria with $\text{concentrations}\text{\$}\text{?}\text{= 10}{}^{\mathrm{?5}}\text{M}$. This effect depends on the molar bencyclane concentration of the incubation medium, and is not abolished by the addition of atractyloside, oligomycin or ruthenium red. Therefore, it is suggested that uncoupling of oxidative phosphorylation is the reason for this bencyclane effect. Theoretically, both of the described effects result in a reduction of the amount of ATP in the living cell. Possible consequences on myocardial function and the cardiovascular system are discussed in terms of previously published data in this field.     

Similar activities of nerve growth factor and its homologue proinsulin in intracellular hydrogen peroxide production and metabolism in adipocytes: Transmembrane signalling relative to insulin-mimicking cellular effects

Generation of hydrogen peroxide in adipocyte plasma membrane and its intracellular metabolism and regulatory role have been shown by Mukherjee and co-workers to be a major effector system for insulin [Fedn Proc.35, 1694 (1976); Archs Biochem. Biophys.184, 69 (1977); Biochem. Pharmac.27, 2589 (1978); Fedn Proc.37, 1689 (1978); and Biochem. Pharmac.29, 1239 (1980)]. The possible involvement of this mechanism in the action of structurally similar polypeptides having some insulin-like metabolic effects was investigated. The β-subunit of nerve growth factor (2.5 S NGF, mol. wt 13,500) which has a striking structural homology with proinsulin and has been reported to exert certain insulin-like metabolic effects in its own target tissues (e.g. growing neurites and sympathetic ganglia), and the insulin-derived polypeptides, desalanine-insulin and desoctapeptide-insulin, as well as proinsulin, were examined for their effects on rat adipocytes, employing the technique of formate oxidation. Both NGF and proinsulin caused increased [¹⁴C]formate oxidation, showing similar intrinsic activities, up to a maximum of 140–160% of the basal rate; insulin increased the rate to 190–210% of the basal rate. The relative potencies of the hormones toward H₂O₂ formation and stimulation of the pentose phosphate pathway activity were: insulin $\text{(}\text{EC}{}_{50}\text{: 2.5 × 10}{}^{\mathrm{?11}}\text{M}\text{)}$, desalanine-insulin $\text{(}\text{EC}{}_{50}\text{: 2.5 × 10}{}^{\mathrm{?10}}\text{M}\text{)}$ , proinsulin $\text{(}\text{EC}{}_{50}\text{: 8 × 10}{}^{\mathrm{?9}}\text{M}\text{)}$, and NGF $\text{(}\text{EC}{}_{50}\text{: 10}{}^{\mathrm{?9}}\text{M}\text{)}$. The biologically inactive derivative, desoctapeptide-insulin, did not stimulate glucose oxidation, although it caused a small increase in formate oxidation, with an $\text{EC}{}_{50}\text{of}\text{5 × 10}{}^{\mathrm{?7}}\text{M}$, indicating a suboptimal level of H₂O₂ formation in the elevation of the hexose monophosphate shunt activity. 3-Amino-1,2,4,-triazole (50 mM), which irreversibly decomposes the peroxidatic compound II of the catalase: H₂O₂ complex, inhibited formate oxidation to a greater extent in the hormone-treated cells than in the control cells, whereas sodium azide, an inhibitor of the hemoprotein, catalase, completely inhibited it. The abilities of the polypeptides to stimulate H₂O₂ formation correlated with their abilities to promote lipogenesis from [U-¹⁴C]-D-glucose, as expected of insulin. The cellular GSH/GSSG ratio increased concomitantly with the stimulation of glucose oxidation via the shunt, indicating a tight coupling between these processes. The results confirm that the hydrogen peroxide production is a common basis of the metabolic actions of growth-promoting polypeptide hormones or mitogens beyond their respective receptors.     

The effects of cadmium, manganese and aluminium on sodium-potassium-activated and magnesium-activated adenosine triphosphatase activity and choline uptake in rat brain synaptosomes

The effects of Cd²⁺, Mn²⁺ and Al³⁺ on rat brain synaptosomal sodium-potassium-activated and magnesium-activated adenosine triphosphatase (Na-K-ATPase and Mg-ATPase) activity and choline uptake were studied. All three types of metal ions inhibited Na-K-ATPase activity more markedly than Mg-ATPase activity. The rank order of inhibition of Na-K-ATPase was: $\text{Cd}{}^{\mathrm{2+}}\text{(}\text{ic}{}_{50}\text{= 5.4 μ}\text{M}\text{) >}\text{Mn}{}_{\mathrm{2+}}\text{(}\text{ic}{}_{50}\text{= 955 μ}\text{m}\text{) >}\text{Al}{}^{\mathrm{3+}}\text{(}\text{ic}{}_{50}\text{= 8.3}\text{mM}$). The rank order of inhibition of Mg- was:$\text{Cd}{}^{\mathrm{2+}}\text{(}\text{ic}{}_{50}\text{= 316 μ}\text{M}\text{>}\text{Mn}{}^{\mathrm{2+}}\text{(}\text{ic}{}_{50}\text{= 5.5}\text{mM}\text{>}\text{Al}{}^{\mathrm{3+}}\text{(}\text{ic}{}_{50}\text{= 21.9}\text{mM}\text{).}\text{Al}{}^{\mathrm{3+}}$ was most potent in inhibiting synaptosomal choline uptake ($\text{ic}{}_{50}\text{= 24μ}\text{M}$ in the absence of Ca²⁺ and 123 μ.M in the presence of 1 mM Ca²⁺). $\text{Cd}{}^{\mathrm{2+}}\text{(}\text{ic}{}_{50}\text{= 363 μ}\text{M}\text{)}$ was a more effective inhibitor of choline uptake than $\text{Mn}{}^{\mathrm{2+}}\text{(}\text{ic}{}_{50}\text{= 1.2?1.5}\text{mM}\text{)}$ . The presence of 1 mM Ca²⁺ did not alter choline uptake, nor did it antagonize the inhibitory actions of the three metals. Our observations that Cd²⁺ and Al³⁺ inhibited synaptosomal choline uptake, but did not show parallel inhibitory effects on Na-K-ATPase activity directly contradicts the ionic gradient hypothesis. These results are also discussed in relation to the in vivo neurotoxicity of cadmium, manganese and aluminium.     

Kinetic studies on the deethylation of ethoxybenzamide: A comparative study with isolated hepatocytes and liver microsomes of rat

Kinetic parameters (K_m and V_max) of ethoxybenzamide deethylation in isolated rat hepatocytes and liver microsomes were compared. Adjustment of cofactors in microsomal deethylation, such as NADPH and Mg²⁺, to give optimum conditions, and appropriate correction of the apparent kinetic parameters for nonspecific binding and microsomal yield resulted in good agreement among the kinetic parameters of isolated hepatocytes [$\text{V}{}_{\mathrm{<mtext>max</mtext>}}\text{= 0.0863 μmole · min}{}^{\mathrm{?1}}\text{· (g liver)}{}^{\mathrm{?1}}$ and K_m = 0.459 mM] and microsomes [V_max = 0.124 μmoles · min^?1 · (gliver)^?1 and K_m = 0.378 mM].     

Extrapineal amine N-acetylation in rat brain: Regional and subcellular distribution and enzyme kinetics

Analysis by thin-layer chromatography showed that $\text{[}{}^{14}\text{C}\text{]N-}\text{acetyltryptamine and}\text{[}{}^{14}\text{C}\text{]N-}\text{acetyl}\text{-β-}\text{phenylethylamine}$ are formed from the incubation of [¹⁴C]acetyl-CoA with tryptamine or β-phenylethylamine. respectively, in the presence of rat brain extracts. The specific activity of the N-acetyltransferase in fifteen discrete regions of rat CNS ranged from 1.64 ± 0.05 nmoles of product formed/mg of protein/hr in cerebellum to 0.57 ± 0.05 nmole in occipital cortex with tryptamine as substrate, and from 2.80 ± 0.30 nmoles in cerebellum to 0.91 ± 0.13 nmole in cervical cord with β- phenylethylamine as substrate. Comparison of the regional specific activities in the presence of the respective substrates yielded a correlation coefficient of 0.83 (P < 0.01). In cerebellum N-acetyltransferase activity appears exclusively in cytosol. At two stages of purification (i.e. after Bio-Gel fractionation as well as after ammonium sulfate precipitation), the enzyme exhibited biphasic kinetics with respect to acetyl-CoA in the presence of tryptamine or β-phenylelhylamine and with respect to either substrate in the presence of acetyl-CoA.     

Studies of the metabolism of N-methyl containing anti-tumour agents: 14CO2 breath analysis after administration of 14C-labelled N-methyl drugs, formaldehyde and formate in mice

The ¹⁴CO₂; content of the breath was analysed after administration of the following N-¹⁴ CH₃ labelled drugs to mice: aminopyrine, hexamethylmelamine (HMM), pentamethylmelamine (PMM), procarbazine and caffeine. Except for aminopyrine, the ¹⁴CO₂; exhalation rate plots declined monophasically with half lives of 91 min ([¹⁴C]-HMM), 97 min ([¹⁴C]-PMM), 68 min ([¹⁴C]procarbazine) and 92 min ([¹⁴C]caffeine). The ¹⁴CO₂ exhalation rate peaked rapidly after aminopyrine administration and declined bi-phasically with an initial $\text{t}{}_{\mathrm{<mtext>1</mtext><mtext>2</mtext>}}$ of 15 min and a terminal $\text{t}{}_{\mathrm{<mtext>1</mtext><mtext>2</mtext>}}$ of 126 min. The ¹⁴CO₂; plots after both [¹⁴C]-HMM and [¹⁴C]aminopyrine were influenced by pre-treatment of mice with proadifen. Pretreatment with phenobarbitone shortened the $\text{t}{}_{\mathrm{<mtext>1</mtext><mtext>2</mtext>}}$ of the ¹⁴CO₂ appearance rate after [¹⁴C]HMM by 24% but did not change the ¹⁴CO₂ curve after administration of [¹⁴C] aminopyrine. The ¹⁴CO₂ exhalation rate plots after administration of H¹⁴CHO and H¹⁴COOH were virtually identical with that obtained after [¹⁴C]aminopyrine and not influenced by either proadifen or phenobarbitone pretreatment. The ¹⁴CO₂ exhalation rate profile obtained on metabolism of [¹⁴C]aminopyrine in mice thus appears to be determined by the rate of the oxidation of formaldehyde or formate to CO₂. Only 24% of the label injected with the N-methyl moieties of [¹⁴C]HMM and 21% of the label in [¹⁴C]procarbazine were exhaled as ¹⁴CO₂, whereas 49% of the N-¹⁴CH₃ in [¹⁴C]aminopyrine were metabolized to ¹⁴CO₂. It remains to be determined whether this difference and the difference in the shapes of the ¹⁴CO₂ exhalation profiles obtained with the cytotoxic N-¹⁴CH₃ drugs as compared to [¹⁴C]aminopyrine, are related to the biochemical processes mediating their antineoplastic activity.     

The Ah regulatory gene product. Survey of nineteen polycyclic aromatic compounds' and fifteen benzo[a]pyrene metabolites' capacity to bind to the cytosolic receptor

The capacity of 19 polycyclic aromatic compounds and 15 benzo[a]pyrene metabolites to displace $\text{[1,6-}{}^3\text{H}\text{]2,3,7,8-}\text{tetrachlorodibenzo}\text{-p-}\text{dioxine}\text{([}{}^3\text{H]Tcdd}\text{)}$ from the mouse liver cytosolic Ah receptor was examined. We compared our data with various parameters taken from previously published results: the capacity of seven polycyclic hydrocarbons to induce aryl hydrocarbon hydroxylase (AHH) activity in human cell cultures, the capacity of 10 polycyclic hydrocarbons to induce azo dye N-demethylase activity in rat liver, the capacity of 6 polycyclic hydrocarbons to shorten zoxazolamine paralysis times in the intact rat, and the capacity of 15 benzo[a]pyrene metabolites to induce AHH activity in rat hepatoma H-4-II-E cultures. An excellent correlation is seen between the capacity to displace the radioligand from the Ah receptor and the capacity to induce these monooxygenase activities. Differences in the rate of cellular uptake and formation of alkali-extractable metabolites of dibenzo[a,h]anthracene, 3-methylcholanthrene, and benzo[a]anthracene in Hepa-1 mouse hepatoma cell cultures do not account for differences in the capacity of these three polycyclic hydrocarbons to displace [³H]TCDD from the Ah receptor.     

A sensitive enzymatic assay for dextro- or levo-tranylcypromine in brain.

A sensitive assay for (+)- or (?)-tranylcypromine in brain is described that is based on the enzymatic transfer of ¹⁴C-methyl of $\text{S-}\text{adenosyl}\text{-}\text{l}\text{-}\text{methionine}\text{-}{}^{14}\text{C}$ to tranylcypromine by rabbit lung N-methyltransferase. The assay is sensitive enough to measure the drugs in small samples of brain and simple enough so that many assays can be performed in a single day. Studies with amine-containing compounds indicate that other drugs might also be assayed in brain by this procedure.     

A fluorescent analogue of methotrexate as a probe for folate antagonist molecular receptors

A dansyl-l-lysine analogue of methotrexate, $\text{N}{}^{\mathrm{\alpha }}\text{-(}\text{4-amino-4-deoxy-10-methylpteroyl}\text{)-N}{}^{\mathrm{\epsilon }}\text{-(5-[N,N-}\text{dimethylamino]-1-naphthalenesulfonyl]-1-naphthalenesulfonyl)-}\text{l}\text{-lysine}$, is a potent inhibitor of murine L1210 dihydrofolate reductase. The dansyl fluorescence emission was enhanced approximately 3-fold with a 10 nm blue shift upon binding to L1210 dihydrofolate reductase. The fluorescent analogue was only 10-fold less potent than methotrexate in inhibiting the growth of methotrexate-sensitive and -resistant L1210 cells and competes effectively for [³H]methotrexate transport with a K_i of 7.02 μM, a value virtually identical to the K_t for methotrexate in both cell lines. In addition, strong dansyl fluorescence was found to be associated with dihydrofolate reductase from methotrexate-resistant, dihydrofolate reductase-overproducing L1210 cells following incubation of viable cells with the fluorescent methotrexate analogue for 4 hr. The results demonstrate that the dansyl-l-lysine analogue of methotrexate was rapidly transported into L1210 cells where it formed a high-affinity, fluorescent complex with intracellular dihydrofolate reductase.     

Electrocortical changes induced by perfusion of catecholamines into the brainstem reticular formation

Various concentrations of noradrenaline and related catecolamines were perfused bilaterally into the pontine and mesencephalic reticular formation using push-pull cannulae. The initial effect of a 5-min perfusion of (-)-noradrenaline, (-)-adrenaline, (-)-phenylephrine or α-methyl noradrenaline, was to induce a two stage change in the electrocortical activity, that is, phasic followed by tonic desynchronisation. When high concentrations of these substances were used, a secondary sedative effect correlated with the appearance of slow wave (2–4 Hz) activity in the electrocorticogram was observed. In contrast, (-)-isoproterenol, even in high concentrations, did not produce secondary sedative effects.Using tritium labelled (±)-[7-³H]-noradrenaline in the 10^?6 to 10^?3m concentration range, it was established that the total amount of drug diffusing into the brain tissue was very low. The appearance of phasic electrocortical changes correlated with 0·4–25 ng noradrenaline (base) within the brain at the end of each cannula. Tonic electrocortical desynchronization which appeared when $\text{9 × 10}{}^{\mathrm{?5}}\text{m}\text{to}\text{7 × 10}{}^{\mathrm{?4}}\text{m}$ solutions were used, gave tissue levels of exogenous noradrenaline (base) of 6·5–103 ng. Secondary sedative effects were usually observed with tissue levels in excess of 98 ng at the end of each cannula.     

Interactions between Δ9-Tetrahydrocannabinol and phencyclidine hydrochloride in rats

Δ⁹-Tetrahydrocannabinol (THC; 2.5, 51.0 mg/kg, PO) impaired avoidance and rotarod performance, and caused bradycardia and hypothermia. Phencyclidine (PCP; 1.25, 2.5, 5.0 mg/kg, IP) impaired avoidance and rotarod performance and caused a marked increase in photocell activity. When combined, the depressant properties of each drug were enhanced and the stimulation of photocell activity caused by PCP was antagonized by THC. Tolerance to many of the effects of 10.0 mg/kg THC and its interations with PCP followed subacute treatment for six days, whereas many of the effects of PCP were enhanced after subacute treatment with a dose of 2.5 mg/kg. Open-field behavior was affected by each drug alone and in combination in a similar way as photocell activity, but the depression caused by their interaction was greater; both drugs caused an increase in urination. Response rates on an FR-10 schedule of food reinforcement were decreased by 2.5 mg/kg PCP, but not by 5.0 mg/kg THC; the combination caused greater response suppression than either drug alone. The functional interactions between THC and PCP were not related to changes in the concentrations of ¹⁴C or ³H in plasma or brain derived from ${}^{14}\text{C}\text{-Δ}{}^9\text{-}\text{THC and}{}^3\text{H-PCP}$, respectively     

Bromhexine: in vitro and in vivo studies of release from mono- and bi-component preparations

The in vitro dissolution characteristics of bromhexine and its hydrochloride salt have been investigated in the presence and absence of a cephalosporin antibiotic, Bioavailability of the salt and of the antibiotic from combination capsules have also been studied. In conditions typical of dissolution tests for formulated products, no significant differences were observed in the in vitro dissolution rates of the base and its salt in mono-component preparations. Some slowing of solution rate of the base was observed in bi-component preparations. In vivo, peak plasma levels of bromhexine hydrochloride and cefaclor were $\text{18.1 ± 2.3}\text{ng}\text{”}\text{ml}{}^{\mathrm{?1}}$ and $\text{15.3 ± 0.9 μ}\text{g}\text{”}\text{ml}$^?1, respectively, from the combination formulation and were similar to levels found with the mono-component preparations.     

Concentrations of nitrate in normal human urine and the effect of nitrate ingestion

A method suitable for the analysis of nitrate in human urine was developed. Normal urinary concentrations of nitrate in urine of human volunteers in Dade County, Florida, where the drinking water contains negligible amounts of nitrate, averaged 47.6 ppm of $\text{NO}{}_3{}^{\mathrm{?}}$ (SD = 17.3). On a vegetable and preserved-meat-free diet, the nitrate concentration was reduced (10 to 30 ppm of $\text{NO}{}_3{}^{\mathrm{?}}$), but, on nitrate-supplemented drinking water, the urinary concentration rose to a range of 34–87 ppm of $\text{NO}{}_3{}^{\mathrm{?}}$. A high vegetable diet resulted in peak urinary nitrate concentrations of 270–425 ppm. These results indicated that nitrate in drinking water is a factor in determining urinary nitrate concentration, but that vegetable ingestion is of greater significance.